Abstinence not required: How a Baltimore drug treatment program prioritizes saving lives

A mobile clinic in Baltimore is expanding access to buprenorphine, a medication that treats opioid use disorder by reducing cravings and withdrawal symptoms. The city’s “Healthcare on the Spot” program

Related Keywords

Maryland ,United States ,Johns Hopkins University ,Baltimore Upton ,Anthony Kelly ,Letitia Dzirasa ,Johns Hopkins University School Of Medicine ,Baltimore City Health Department ,Johns Hopkins University School ,Features ,Health ,News ,